Pasithea Therapeutics Corp.
Organization details
- Legal name
- Pasithea Therapeutics Corp.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Miami Beach
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- KTTA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001841330
- EIN
- 85-1591963
Board of directors
-
Alfred J. Novak · DirectorSince 2024
-
Emer Leahy · DirectorSince 2024
-
Lawrence Steinman · DirectorSince 2023
-
Simon Dumesnil · DirectorSince 2024
-
Tiago Marques · Director · Chief Executive OfficerSince 2024
Chief executives
Director election results
Annual meeting of September 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.2%
-
99.6%
Board connections
2 of this board's directors also sit on 2 other boards. 1 is in the same sector.
- via Lawrence Steinman
-
Intensity Therapeutics Inc. Same sectorvia Emer Leahy
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $202,999
- 4 purchases by 4 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | Coastlands Capital LP 10% owner | Open-market purchase | +100,000 | $0.53 | $53,000 |
| Nov 28, 2025 | Lawrence Steinman Director | Open-market purchase | +133,333 | $0.75 | $100,000 |
| Nov 28, 2025 | Schneiderman Daniel H Officer (Chief Financial Officer) | Grant or award | +26,667 | $0.75 | $20,000 |
| Nov 28, 2025 | Tiago Marques Director, Officer (Chief Executive Officer) | Open-market purchase | +33,333 | $0.75 | $25,000 |
| Nov 28, 2025 | Simon Dumesnil Director | Open-market purchase | +33,333 | $0.75 | $25,000 |
| Nov 28, 2025 | Emer Leahy Director | Grant or award | +33,333 | $0.75 | $25,000 |
| May 12, 2025 | Tiago Marques Director, Officer (Chief Executive Officer) | Open-market sale | −960 | $0.83 | $797 |
| Jun 13, 2024 | Alfred J. Novak Director | Grant or award | +2,750 | $5.62 | $15,455 |
| Jun 12, 2024 | Alfred J. Novak Director | Grant or award | +750 | $5.61 | $4,208 |
| Jun 2, 2023 | Lawrence Steinman Director | Open-market purchase | +30,000 | $0.43 | $12,900 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Pasithea Therapeutics Corp.
Who is the CEO of Pasithea Therapeutics Corp.?
Tiago Marques is Pasithea Therapeutics Corp.'s Chief Executive Officer.
How many directors are on Pasithea Therapeutics Corp.'s board?
Pasithea Therapeutics Corp.'s board has 5 directors: Alfred J. Novak, Emer Leahy, Lawrence Steinman, Simon Dumesnil and Tiago Marques.
Are Pasithea Therapeutics Corp. insiders buying or selling shares?
Over the last 12 months, Pasithea Therapeutics Corp. insiders bought $202,999 of shares in 4 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="pasithea-therapeutics-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.